Meiji Indonesian Pharmaceutical Industries

PT Meiji Indonesian Pharmaceutical Industries is a prominent pharmaceutical manufacturer based in Indonesia and a subsidiary of the Japanese firm Meiji Seika Pharma Co., Ltd. Established in 1974, the company has established itself as a leader in the production of high-quality antibiotics, including penicillin and non-penicillin derivatives, for both domestic and international markets. Operating from a state-of-the-art, GMP-certified facility in Bangil, East Java, Meiji Indonesia produces a wide range of prescription drugs, over-the-counter medicines, and health supplements. The company serves as a strategic production hub for the Meiji Group in Southeast Asia, exporting its products to numerous countries. Its commitment to international quality standards has made it a trusted partner in the regional healthcare sector.